ExpressPoints Contemporary Management of Hemophilia A: Expert Guidance to Improve Patient Outcomes

Download this summary slideset of key takeaways from a CCO Live Webinar for expert insight on contemporary best practice management of hemophilia A, including prophylaxis, improving adherence, and emerging strategies to improve patient outcomes.
Michael Callaghan, MD
Miguel A. Escobar, MD
person default
Rebecca Kruse-Jarres, MD, MPH
Format: Microsoft PowerPoint (.ppt)
File Size: 495 KB
Released: December 10, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Genentech, a member of the Roche Group
Sanofi Genzyme Corporation
Takeda Pharmaceutical Company Ltd

Related Content

Download this short slideset from Clinical Care Options (CCO) on the management of newly diagnosed and relapsed light-chain (AL) amyloidosis

Ankit Kansagra, MD Shaji K. Kumar, MD Vaishali Sanchorawala, MD Released: January 19, 2022

Downloadable PDF summary transcript of expert answers to questions on hemophilia A management, from Clinical Care Options (CCO)

Miguel A. Escobar, MD Mark Reding, MD Guy A. Young, MD Released: January 18, 2022

Downloadable summary slideset from a live ASH 2021 satellite symposium on optimizing outcomes in hemophilia A with factor and nonfactor therapy from Clinical Care Options (CCO)

Miguel A. Escobar, MD
Program Director
Mark Reding, MD Guy A. Young, MD
Released: December 21, 2021

Efficacy and safety in the ATLAS-INH trial of fitusiran for hemophilia A or B with inhibitors presented at ASH 2021, as reported by Clinical Care Options (CCO)

Released: December 21, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings